@article {242, title = {Antibiotics Therapeutic Interchanges: A Narrative Reviews}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {9}, year = {2020}, month = {February 2020}, pages = {14-19}, type = {Review Article }, chapter = {14}, abstract = {

Objective: To review the antibiotics therapeutic interchanges. Methods: It is an extensive search, or fifty databases included the following through the Saudi Digital Library (SDL) searching engine. It included the various type of studies (meta-analysis, randomized controlled studies and observational studies) in the English language with human study only for the update May 2017. The search in terms of therapeutic interchange, medication, therapy and type of disease or medication base on therapeutics class of anti-psychiatric. The medication list and switch from one drug to substitute based on the literature found the search that has included comparative safety, efficacy and cost of the type of medication for each disease and national or international evidence-based guidelines. Results: The total number of studies after an extensive search with a specific term search was 487 studies. Of those, there were 107 duplicated studies, and 380 studies included for future evaluation. After evaluation, there were 27 studies discussed the therapeutic interchange of antibiotics. Of those 27 studies, eight studies included for evaluation. Conclusion: Antibiotics therapeutic interchange system properly applicable implementation in practice. Further studies mandate to validate antibiotic therapeutic interchange. Antibiotic therapeutic interchange is highly recommended in the Kingdom of Saudi Arabia.

}, keywords = {Antibiotics, Drug, Literature, Review, Therapeutic interchanges, Therapy}, doi = {10.5530/ijpcs.2020.9.4}, author = {Yousef Ahmed Alomi and Faiz Abdullah Bahadig} } @article {243, title = {Asthma Disorders Therapeutic Interchanges Drug : A Narrative Reviews}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {9}, year = {2020}, month = {August 2020}, pages = {94-97}, type = {Review Article}, chapter = {94}, abstract = {

Objective: To analysis the anti-asthmatic medications therapeutic interchanges drug therapy. Methods: It is an extensive search, or fifty databases comprised the following through the Saudi Digital Library (SDL) searching engine. It encompassed the various types of studies (meta-analysis, randomized controlled studies and observational studies) in the English language with human study only for the update May 2017. The search in terms of therapeutic interchange, medication, therapy and type of disease or medication base on therapeutics class of Anti-psychiatric. The medication list and switch from one drug to another based on the literature found the search that has included comparative safety, efficacy and cost of the type of medication for each disease and national or international evidence-based guidelines. Results: The total number of studies after an extensive search with a specific term search was 487 studies. Of those, there were 107 duplicated studies, and 380 studies included for future assessment. After assessment, there were 14 studies about therapeutic interchange of medicines for asthma. Of those 14 studies, one study included for evaluation. Conclusion: Anti-asthmatic therapeutic interchange studies are occasionally finding in the literature. International asthma management guidelines as an alternative interchange of this matter. Further studies claim to standardized anti-asthmatic therapeutic interchange pharmacy field.

}, keywords = {Asthma, Drug, Literature, Review, Therapeutic interchanges, Therapy}, doi = {10.5530/ijpcs.2020.9.18}, author = {Yousef Ahmed Alomi and Faiz Abdullah Bahadig} } @article {241, title = {Cardiovascular Medications Therapeutic Interchanges: A Narrative Reviews}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {9}, year = {2020}, month = {May 2020}, pages = {51-58}, type = {Review Article }, chapter = {51}, abstract = {

Objective: To review the cardiovascular medications therapeutic interchanges. Methods: It is an extensive search, or fifty databases included the following through the Saudi Digital Library (SDL) searching engine. It included the various types of studies (meta-analysis, randomized controlled studies and observational studies) in the English language with human study only for the update May 2017. The search in terms of therapeutic interchange, medication, therapy, type of disease or medication base on therapeutics class of anti-psychiatric. The medication list and switch from one drug to alternative based on the literature found the search that has included comparative safety, efficacy and cost of the type of medication for each disease and national or international evidence-based guidelines. Results: The total number of studies after an extensive search with a specific term search was 487 studies. Of those, there were 107 duplicated studies, and 380 studies included for future evaluation. After evaluation, there were 64 studies about therapeutic interchange of cardiovascular medications. Conclusion: The cardiovascular therapeutic interchange studies are wide-ranging and common available findings in the literature. Most of the studies have observational non-randomized. Comparative studies published in management guidelines as an alternative interchange of this matter. Cardiovascular therapeutic interchanges are highly recommended for execution in the Kingdom of Saudi Arabia.

}, keywords = {Cardiovascular, Drug, Literature, Review, Therapeutic interchanges, Therapy}, doi = {10.5530/ijpcs.2020.9.10}, author = {Yousef Ahmed Alomi and Faiz Abdullah Bahadig} } @article {61, title = {National Survey of the Pharmacokinetics Services at the Ministry of Health Hospitals in Saudi Arabia: Drug Therapy Monitoring and Healthcare Professional Education}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {8}, year = {2019}, month = {June 2019}, pages = {99-104}, type = {Research Article}, chapter = {99}, abstract = {

Objectives: A clinical pharmacist offers vital support in the expansion of a final prescription with improved patient management and enhanced safety. The aim of the current study to explore the Pharmacokinetics services at Ministry of Health (MOH) hospitals in Saudi Arabia with an emphasis on drug therapy monitoring and patient{\textquoteright}s education. Methods: This is a 2-months cross-sectional national survey related to the Pharmacokinetics services with a focus on drug therapy monitoring and education of pharmacist at MOH hospitals in Saudi Arabia. The study consisted of two parts; the first part captures demographic information and the second part contained 43 questions designed by the authors. It was derived from American Society of Health-System Pharmacists (ASHP) guidelines and from the literature. We used the 5-point Likert response scale system to obtain responses of the participants; there were close-ended questions. The electronic questionnaire was distributed to all the coordinators of the clinical pharmacy services or to the drug information centers at MOH hospitals. All analysis was done through survey monkey system. Results: A total of 43 hospital pharmacies returned the survey, for a response rate of 86\%. The most clinical pharmacokinetics services documented were drug quality reporting 34 (87.18\%), drug information inquiries 35 (83.33\%), adverse drug reaction 35 (81.40\%) and medication error 35 (81.40\%). Highest clinical impact and cost avoidance of clinical Pharmacokinetics services were drug information inquiries 25 (60.98\%), the drug quality reporting system 21 (53.85\%) and pharmacist intervention 21 (52.5\%). Analysis of monthly workload for clinical Pharmacokinetics services were a number of drug information inquiries 28 (70\%) and the number of prescriptions needs 25 (64.1\%). The clinical Pharmacokinetics services education and training for pharmacists were found at average 7.8 (20.89\%) hospitals with high percentages type of educations was short education course 1-5 days [15 (39.47\%)] and long training course 4-5 weeks [8 (21.05\%)]. While Pharmacokinetics services education and training for healthcare provider were found at main 6 (15.66\%) hospitals only with high percentages type of educations was short education course 1-5 days [8 (20.00\%)] and Pharmacokinetics competencies 7 (18.92\%). Conclusion: Pharmacokinetics services on drug therapy monitoring was not competent at half MOH hospital, while only few of the hospitals had pharmacokinetics education and training to offer. Implementing the MOH pharmacokinetics services strategy with an emphasis on the drug therapy monitoring with education and training is required at all MOH hospitals in Saudi Arabia.

}, keywords = {Education, Healthcare, Ministry of Health, Monitoring, Pharmacokinetics Services, Saudi Arabia, Therapy}, doi = {10.5530/ijpcs.2019.8.17}, author = {Yousef Ahmed Alomi and Rasha Abdelsalam Elshenawy and Sultan Mohammed Al-Jarallah} }